A Phase III Trial of PPP001 (Smokeable Marijuana) in Advanced Cancer Patients

Status: Suspended

Phase of Trial: Phase III

Latest Information Update: 11 Feb 2019

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Feb 2019 According to a Tetra Bio Pharma media release, the company has suspended the Phase III clinical program for PPP001 due to impurities found in the product. This suspension does not affect the timing of the European application. the company will take the next 6 months to assess the situation and propose a robust quality program to Health Canada.
05 Feb 2019 Status changed from recruiting to suspended, according to a Tetra Bio Pharma media release.
13 Jun 2018 According to a Tetra Bio Pharma media release, the company expects to complete this trial in Q4 of 2018 or Q1 of 2019 and will file for approval in Q1 of 2019.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com